At the end of September, long-time MarketWatch contributor Mark Hulbert wrote a piece that argued the S&P 500 was still overvalued despite a recent 6% correction. Since that article appeared, the index has gained another 5%, suggesting the November rally has produced several overbought stocks. Hulbert’s article pointed out that the average price-to-sales and price-to-earnings
0 Comments
I’ve been guilty over the last several years of creating an us versus them situation regarding Advance Micro Devices (NASDAQ:AMD) and Nvidia (NASDAQ:NVDA). While I’m partial to the latter, owning AMD stock is not wrong. Not by a long shot.  InvestorPlace contributor Dana Blankenhorn recently discussed why he still owns AMD. He pointed out that
0 Comments
The world has continuously demanded technology. Hence, electric vehicle (EV) companies have experienced increased demand in the past few years. The increasing sales of electric vehicles are an evident manifestation of such a demand. Over 6 million new battery electric vehicles (BEV) and plug-in hybrids (PHEV) were sold in the first half of 2023 in
0 Comments
In this article BRK.A Follow your favorite stocksCREATE FREE ACCOUNT Warren Buffett (L), CEO of Berkshire Hathaway, and vice chairman Charlie Munger attend the 2019 annual shareholders meeting in Omaha, Nebraska, May 3, 2019. Johannes Eisele | AFP | Getty Images Charlie Munger’s unique partnership with Warren Buffett, spanning over half a century, helped forge
0 Comments
The Dow Jones Industrial Average, or Dow, is an index of 30 well-known blue-chip stocks. The index has been in existence since 1896, making it one of the oldest stock market barometers in the world. Today, investors view the Dow as a bellwether for the United States market and economy. After lagging the benchmark S&P
0 Comments
Cannabis has undoubtedly taken ground within the medical and recreational world. A review of several analyst opinions in different financial sources shows these three companies with good opinions and long-term prospects. These three top-rated cannabis stocks are having incredible development and growth worth analyzing. Buying stock in these companies can be positive for your portfolio
0 Comments
SoFi (NASDAQ:SOFI) reported solid third-quarter results, and I’m much less worried about the company’s loan portfolio than I was. Still, SOFI stock remains overvalued, making the name unattractive for investors to buy at this point. Strong Q3 Results SoFi’s top line jumped 27% versus the same period a year earlier to $537 million. Meanwhile, EBITDA,
0 Comments
Undeniably, the concept of growth penny stocks represent one of the hottest topics on Wall Street. And this interest goes well beyond the meme-stock phenomenon that characterized much of the market action during the post-pandemic period. Seemingly, each generation of investors have their special phase with these speculative entities. From a moral perspective, there’s nothing
0 Comments